DK0745387T3 - Adjuvanser til virale vacciner - Google Patents

Adjuvanser til virale vacciner

Info

Publication number
DK0745387T3
DK0745387T3 DK96303835T DK96303835T DK0745387T3 DK 0745387 T3 DK0745387 T3 DK 0745387T3 DK 96303835 T DK96303835 T DK 96303835T DK 96303835 T DK96303835 T DK 96303835T DK 0745387 T3 DK0745387 T3 DK 0745387T3
Authority
DK
Denmark
Prior art keywords
adjuvants
viral vaccines
adjuvant
compositions
squlane
Prior art date
Application number
DK96303835T
Other languages
English (en)
Inventor
Richard Norman Hjorth
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23825435&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0745387(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of DK0745387T3 publication Critical patent/DK0745387T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
DK96303835T 1995-06-02 1996-05-29 Adjuvanser til virale vacciner DK0745387T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/459,600 US5718904A (en) 1995-06-02 1995-06-02 Adjuvants for viral vaccines

Publications (1)

Publication Number Publication Date
DK0745387T3 true DK0745387T3 (da) 2005-02-21

Family

ID=23825435

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96303835T DK0745387T3 (da) 1995-06-02 1996-05-29 Adjuvanser til virale vacciner

Country Status (13)

Country Link
US (1) US5718904A (da)
EP (1) EP0745387B1 (da)
JP (1) JP4344017B2 (da)
KR (1) KR970000248A (da)
CN (1) CN1141810A (da)
AT (1) ATE284710T1 (da)
AU (1) AU712972B2 (da)
CA (1) CA2177668C (da)
DE (1) DE69634024T2 (da)
DK (1) DK0745387T3 (da)
ES (1) ES2233955T3 (da)
HU (1) HUP9601466A2 (da)
NZ (1) NZ286699A (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6165481A (en) * 1997-12-25 2000-12-26 Nippon Petrochemicals Company, Inc. Highly pure squalane, raw material for pharmaceuticals and cosmetics prepared by using the same and method for producing the same
AU769539B2 (en) 1999-01-29 2004-01-29 Zoetis Services Llc Adjuvants for use in vaccines
KR100720213B1 (ko) * 2003-04-04 2007-05-21 화이자 프로덕츠 인코포레이티드 미세 유동화된 수중 유적형 유화액 및 백신 조성물
KR20090051129A (ko) * 2004-04-05 2009-05-20 화이자 프로덕츠 인코포레이티드 미세유체화된 수중유 유화액 및 백신 조성물
CN1315533C (zh) * 2004-06-24 2007-05-16 上海市农业科学院畜牧兽医研究所 猪细小病毒油乳剂灭活疫苗
US20060228369A1 (en) * 2005-04-11 2006-10-12 Program For Appropriate Technology In Health Stabilization and preservation of temperature-sensitive vaccines
NZ565512A (en) * 2005-08-02 2011-08-26 Novartis Vaccines & Diagnostic Reducing interference between oil-containing adjuvants and surfactant-containing antigens
FR2896162B1 (fr) * 2006-01-13 2008-02-15 Sanofi Pasteur Sa Emulsion huile dans eau thermoreversible
PL1991266T3 (pl) * 2006-01-26 2013-11-29 Zoetis Services Llc Nowe kompozycje adiuwantów glikolipidowych
US7682619B2 (en) * 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
ITFI20060163A1 (it) * 2006-06-29 2006-09-28 Menarini Internat Operations Luxembourg Sa Composizione farmaceutica contenente un anticorpo monoclonale anti idiotipico anti-ca-125 ed alluminio
US20090181078A1 (en) * 2006-09-26 2009-07-16 Infectious Disease Research Institute Vaccine composition containing synthetic adjuvant
LT2484375T (lt) 2006-09-26 2018-07-10 Infectious Disease Research Institute Vakcinos kompozicija, turinti sintetinio adjuvanto
GB0622282D0 (en) 2006-11-08 2006-12-20 Novartis Ag Quality control methods
BRPI1011072B1 (pt) 2009-06-05 2021-09-28 Infectious Disease Research Institute Composto de gla, composições de vacina e farmacêutica compreendendo dito composto, bem como uso dos mesmos para estimular, induzir ou acentuar uma resposta imune em um indivíduo
AU2011224245B2 (en) 2010-03-11 2014-12-04 Immune Design Corp. Vaccines for influenza
MX350795B (es) 2011-04-08 2017-09-19 Inmune Design Corp Composiciones inmunogenicas y metodos para utilizar las composiciones para inducir respuestas inmunes humorales y celulares.
WO2012149307A2 (en) 2011-04-27 2012-11-01 Immune Design Corp. Synthetic long peptide (slp)-based vaccines
PL2850431T3 (pl) 2012-05-16 2018-09-28 Immune Design Corp. Szczepionki przeciwko HSV-2
CN102764431B (zh) * 2012-08-03 2014-10-22 江苏省农业科学院 一种猪支原体肺炎雾化活疫苗及其制备与检验方法
CN104043119B (zh) * 2013-03-13 2016-05-25 上海医药工业研究院 一种新型疫苗佐剂及其制备方法
BR112015025709A2 (pt) 2013-04-18 2017-07-18 Immune Design Corp monoterapia com gla para uso em tratamento de câncer
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis
WO2015136056A1 (en) 2014-03-12 2015-09-17 Bavarian Nordic A/S Use of oil and water emulsions for increasing b cell responses with modified vaccinia ankara virus
EP3843782A1 (en) 2018-08-29 2021-07-07 Centre Hospitalier Universitaire Vaudois (CHUV) Ebola vaccine compositions and methods of using same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4073743A (en) * 1975-04-17 1978-02-14 Merck & Co., Inc. Process for preparing an emulsion
US4466957A (en) * 1982-02-25 1984-08-21 American Home Products Corporation Vaccine adjuvants
DE3446515A1 (de) * 1984-12-20 1986-06-26 Behringwerke Ag, 3550 Marburg Oeladjuvierte vaccine und verfahren zu ihrer herstellung
US4806352A (en) * 1986-04-15 1989-02-21 Ribi Immunochem Research Inc. Immunological lipid emulsion adjuvant
US4803070A (en) * 1986-04-15 1989-02-07 Ribi Immunochem Research Inc. Immunological emulsion adjuvants for polysaccharide vaccines
US5376369A (en) * 1987-11-03 1994-12-27 Syntex (U.S.A.) Inc. Vaccine adjuvant
HU212924B (en) * 1989-05-25 1996-12-30 Chiron Corp Adjuvant formulation comprising a submicron oil droplet emulsion

Also Published As

Publication number Publication date
KR970000248A (ko) 1997-01-21
DE69634024D1 (de) 2005-01-20
JP4344017B2 (ja) 2009-10-14
EP0745387A2 (en) 1996-12-04
CA2177668A1 (en) 1996-12-03
HU9601466D0 (en) 1996-07-29
AU712972B2 (en) 1999-11-18
CA2177668C (en) 2009-02-24
EP0745387A3 (en) 1998-03-11
ES2233955T3 (es) 2005-06-16
ATE284710T1 (de) 2005-01-15
DE69634024T2 (de) 2005-12-08
NZ286699A (en) 1997-10-24
EP0745387B1 (en) 2004-12-15
US5718904A (en) 1998-02-17
JPH08325163A (ja) 1996-12-10
CN1141810A (zh) 1997-02-05
AU5457596A (en) 1996-12-12
HUP9601466A2 (en) 1997-03-28

Similar Documents

Publication Publication Date Title
DK0745387T3 (da) Adjuvanser til virale vacciner
HU9601462D0 (en) Adjuvants for viral vaccines
PT865297E (pt) Composicoes de vacinas para administracao intranasal compreendendo quitosano e suas utilizacoes
DK1113816T3 (da) Influenzavirus-vaccinesammensætning
NO954786L (no) Hjelpestoffer for vaksiner mot åndedretts-syncytalvirus
KR950702125A (ko) 보조약을 함유하는 백신 조성물(vaccine composition containing adjuvants)
EP0634937A1 (en) Vaccines that contain non-ionic surfactant vesicles.
WO1997001640A3 (en) Vaccines against hepatitis c
NO975620L (no) Immunologiske kombinasjonssammensetninger og fremgangsmåter
PT792165E (pt) Composicoes imunogenicas
ATE392429T1 (de) Lebend-impfstoff gegen heliobacter pylori
WO1992006113A3 (en) Derivatives of gp160 and vaccines based on gp160 or a derivative thereof, containing an adjuvant
GB9818133D0 (en) Vaccine
GB9018061D0 (en) Compositions for vaccines
DE60036705D1 (de) Adjuvanskombinationen zur immunisierung und vakzine
DK1204420T3 (da) Trehaloseproducerende prokaryotiske celler som vacciner